510(k) device
Modification to Relief Brief
The JM Kohn Co. · Orthosis, Truncal, For Dysmenorrhea (NJB, Class I) · First FDA decision Aug 12, 2002, newest Aug 12, 2002Endometriosis and pelvic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
40
Naming "Modification to Relief"
MAUDE reports
0
Brand "Modification to Relief", since 2015
PubMed studies
0
Mentioning "Modification to Relief"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Modification to Relief Brief
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K003128 · Decided Aug 12, 2002 · 675 days after receipt
Device type: Orthosis, Truncal, For Dysmenorrhea (NJB) · Physical Medicine & Rehabilitation
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Modification to Relief", any status and sponsor, newest update first.
Cairo UniversityAcademic, hospital or other
NCT07618065 · 88 participants (planned) · Start Oct 1, 2026 · Primary completion Feb 1, 2027
Device: Endermologie-Assisted Physiotherapy; Standard Postoperative Physiotherapy · For: Lower-Limb Lipedema; Lipedema
Sites: Cairo, Egypt · 2 sites in all
Laval UniversityAcademic, hospital or other
NCT07607899 · 24 participants (planned) · Start Sep 14, 2026 · Primary completion Mar 2027
Device: Virtual Reality-Supported Rehabilitation · For: Chronic Pain; Kinesiophobia (Fear of Movement)
Sites: Québec, Canada; Sainte-Marie, Canada
- Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT)Pivotal-lookingActive, not recruiting
CognifiSense Inc.Not on our public-company list
NCT07033195 · 200 participants (planned) · Start Jun 1, 2025 · Primary completion Feb 20, 2027
Device: Skills-based Virtual Reality Therapy; Distraction-based Virtual Reality Therapy · For: Chronic Pain; Chronic Back Pain; Chronic Lower Back Pain (CLBP)
Sites: Boulder, Colorado
37 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Modification to Relief", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NJB
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Modification to Relief"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.